Oxford, United Kingdom Clinical Trials

Adenocarcinoma

Churchill Hospital

Patients are needed to participate in a clinical research study to evaluate Oesophagogastric Cancer

Anemia

John Radcliffe Hospital

Patients are needed to participate in a clinical research study of Oral Azacitidine and Placebo to evaluate Myelodysplastic Syndrome

Oxford University Hospitals NHS Trust

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Atrial Fibrillation

Research Site

Patients are needed to participate in a clinical research study of edoxaban, Enoxaparin and Warfarin to evaluate Atrial Fibrillation

John Radcliff Hospital

A clinical research study of RF Ablation for the treatment of Paroxysmal Atrial Fibrillation

John Radcliffe Hospital

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Bladder Cancer

Research Site

A clinical trial to evaluate treatments using Chemotherapy and MPDL3280A for patients with Bladder Cancer

Blood Cancer

Research Site

A clinical research study of Denosumab and Zoledronic acid

Bone Diseases

Research Site

A clinical research study of Denosumab and Zoledronic acid

Bone Metastases

Research Site

A clinical research study of Denosumab and Zoledronic acid

Breast Cancer

Research Site

A Phase III Trial of Niraparib (a PARP inhibitor) Versus Physician's Choice in Her2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients (BRAVO)

View More »

Research Site

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer

Research Site

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer

Research Site

A clinical research study of Olaparib and Placebo for the treatment of Breast Cancer

Chemotherapy

Churchill Hospital Updated

A clinical research study of Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone and Bortezomib, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone for the treatment of Lymphoma, Large B-Cell, Diffuse

Chronic Lymphocytic Leukemia

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Research Site

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Site Reference ID/Investigator# 119976

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Colorectal Cancer

Dr James East

A clinical trial seeking patients for a research study for the treatment of Colorectal Cancer

COPD (Chronic Obstructive Pulmonary Disease)

GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Coronary Artery Disease

Department of Cardiovascular Medicine, University of Oxford

A clinical trial seeking patients for a research study for the treatment of Coronary Artery Disease

John Radcliffe Hospital Updated

A clinical trial to evaluate treatments using Absorb BVS for patients with Coronary Disease, Coronary Artery Disease or Coronary Restenosis

Research Center GB019

Patients are needed to participate in a clinical research study to evaluate Heart Diseases, Cardiovascular Diseases or 3 Vessel Coronary Artery Disease

Crohn's Disease

Site Reference ID/Investigator# 38196

A clinical trial to evaluate treatments using adalimumab, prednisone and azathioprine for patients with Crohn's Disease

Depression

University of Oxford

A clinical trial seeking patients for a research study for the treatment of Depression

Diabetes Mellitus, Type 2

Oxford Centre for Diabetes, Endocrinology and Metabolism Updated

Clinical trial for Diabetes Mellitus, Type 2

View More »

Churchill Hospital

A clinical research study of GWP42004 and Placebo for the treatment of Diabetes Mellitus, Type 2

Diabetic Macular Edema

Novartis Investigative Site

Patients are needed to participate in a clinical research study of Ranibizumab to evaluate Wet Age Related Macular Degeneration, Diabetic Macular Edema or Retinal Vein Occlusion

Emotional Processing

University of Oxford

A clinical trial seeking patients for a research study for the treatment of Depression

Epilepsy

John Radcliffe Hospital

Patients are needed to participate in a clinical research study to evaluate Epilepsy

Fallopian Tube Cancer

Churchill Hospital

A Phase 2 clinical study for patients with Ovarian Cancer or Fallopian Tube Cancer

Oxford University Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Follicular Lymphoma

Research Site

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

Heart Disease

Research Center GB019

Patients are needed to participate in a clinical research study to evaluate Heart Diseases, Cardiovascular Diseases or 3 Vessel Coronary Artery Disease

Heart Failure

John Radcliffe Hospital

A clinical trial to evaluate treatments using Standard CRT Implant and Pressure-wire guided CRT implant for patients with Heart Failure

John Radcliffe Hospital

Patients are needed to participate in a clinical research study evaluating MPP for the treatment of Heart Failure

Oxford University/John Radcliffe Hospital

A Phase 3 clinical study for patients with Left Ventricular Dysfunction or Heart Failure

Hepatitis

Centre for Clinical Vaccinology and Tropical Medicine

Patients are needed to participate in a clinical research study evaluating MVA-NSmut, AdCh3NSmut and AdCh3NSmut1 for the treatment of Hepatitis C Infection

Hypogonadism

Research Site

Patients are needed to participate in a clinical research study evaluating TAK-448 for the treatment of Hypogonadotropic Hypogonadism

Idiopathic Pulmonary Fibrosis

Churchill Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

In Vitro Fertilization

Oxford Fertility Unit

A clinical research study of Preimplantation Genetic Screening by NGS for the treatment of Infertility or Aneuploidy

Infertility

Oxford Fertility Unit

A clinical research study of Preimplantation Genetic Screening by NGS for the treatment of Infertility or Aneuploidy

Kidney Disease

Churchill Hospital

Patients are needed to participate in a clinical research study of Bortezomib, Thalidomide, Bendamustine and Dexamethasone to evaluate Multiple Myeloma, Chronic Kidney Disease, or Myeloma Renal Failure

Leukemia

Cancer & Haematology Centre, Churchill Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Oxford University Hospitals NHS Trust

A clinical trial to evaluate treatments using Azacitidine and Vorinostat for patients with Leukemia, Myeloid, Acute

Site Reference ID/Investigator# 119976

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Lung Cancer

Churchill Hospital

Patients are needed to participate in a clinical research study of BKM120 to evaluate Carcinoma, Non-Small-Cell Lung

Lung Disease

GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Lymphoma

Research Site

A Phase 3 clinical study for patients with Lymphoma

Research Site

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

Research Site

A clinical research study for the treatment of Hodgkin Lymphoma

Research Site Updated

Patients are needed to participate in a clinical research study of BAY 1238097 to evaluate Neoplasms

Churchill Hospital Updated

A clinical research study of Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone and Bortezomib, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone for the treatment of Lymphoma, Large B-Cell, Diffuse

Lymphoma, B-Cell

Research Site

A Phase 3 clinical study for patients with Lymphoma

Churchill Hospital Updated

A clinical research study of Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone and Bortezomib, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone for the treatment of Lymphoma, Large B-Cell, Diffuse

Macular Degeneration

Novartis Investigative Site

A clinical research study of Ranibizumab for the treatment of Neovascular Age-related Macular Degeneration

Novartis Investigative Site

Patients are needed to participate in a clinical research study of Ranibizumab to evaluate Wet Age Related Macular Degeneration, Diabetic Macular Edema or Retinal Vein Occlusion

Macular Edema

Novartis Investigative Site

Patients are needed to participate in a clinical research study of Ranibizumab to evaluate Wet Age Related Macular Degeneration, Diabetic Macular Edema or Retinal Vein Occlusion

Malignant Melanoma

Research Site

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

NIHR Biomedical Research Centre

A Phase 1 clinical study for patients with Malignant Melanoma

Melanoma

Research Site

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Research Site Updated

Patients are needed to participate in a clinical research study of BAY 1238097 to evaluate Neoplasms

Research Site

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

NIHR Biomedical Research Centre

A Phase 1 clinical study for patients with Malignant Melanoma

Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Metastatic Melanoma

Research Site

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Miscarriage

Research Site Updated

A Phase 2 clinical study for patients with Recurrent Pregnancy Loss or Recurrent Miscarriage

Multiple Myeloma

Research Site

A clinical trial to evaluate treatments using Ixazomib Citrate and Placebo for patients with Multiple Myeloma or Autologous Stem Cell Transplant

Churchill Hospital

Patients are needed to participate in a clinical research study of Bortezomib, Thalidomide, Bendamustine and Dexamethasone to evaluate Multiple Myeloma, Chronic Kidney Disease, or Myeloma Renal Failure

Research Site

A clinical research study of Denosumab and Zoledronic acid

Myelofibrosis

Oxford University Hospitals NHS Trust

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Myocardial Ischemia

Department of Cardiovascular Medicine, University of Oxford

A clinical trial seeking patients for a research study for the treatment of Coronary Artery Disease

John Radcliffe Hospital Updated

A clinical trial to evaluate treatments using Absorb BVS for patients with Coronary Disease, Coronary Artery Disease or Coronary Restenosis

Research Center GB019

Patients are needed to participate in a clinical research study to evaluate Heart Diseases, Cardiovascular Diseases or 3 Vessel Coronary Artery Disease

Neoplasm Metastasis

Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Research Site

A clinical research study of Denosumab and Zoledronic acid

Neoplasms

Research Site Updated

Patients are needed to participate in a clinical research study of BAY 1238097 to evaluate Neoplasms

Research Site

A clinical research study of RO6895882 for the treatment of Neoplasms

Research Site

A clinical research study of vemurafenib for the treatment of Neoplasms

Churchill Hospital

A Phase 2 clinical study for patients with Ovarian Cancer or Fallopian Tube Cancer

Research Site

A clinical research study of Denosumab and Zoledronic acid

View More »

Study Site Oxford

A First-in-human clinical study for patients with Neoplasms

University of Oxford

A Phase 3 clinical study for patients with Carcinoid Tumor of the Small Bowel or Neuroendocrine Tumour

Non-Hodgkin's Lymphoma

Research Site

Patients are needed to participate in a clinical research study evaluating Bendamustine, GDC-0199; ABT-199; RO5537382 and Rituximab [MabThera/Rituxan] for the treatment of Follicular Lymphoma

Non-Small Cell Lung Cancer

GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating GSK2118436 for the treatment of Cancer

Osteosarcoma

Oxford University Hospitals NHS Trust

A Phase 2 clinical study for patients with Osteosarcoma, Advanced Osteosarcoma (MEMOS)

Ovarian Cancer

Churchill Hospital

A Phase 2 clinical study for patients with Ovarian Cancer or Fallopian Tube Cancer

Oxford University Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Peritoneal Cancer

Oxford University Hospitals NHS Trust

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Prostate Cancer

Research Site

Patients are needed to participate in a clinical research study of Enzalutamide and Placebo to evaluate Nonmetastatic Castration-Resistant Prostate Cancer

Pulmonary Fibrosis

Churchill Hospital

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Recurrent Pregnancy Loss

Research Site Updated

A Phase 2 clinical study for patients with Recurrent Pregnancy Loss or Recurrent Miscarriage

Renal Failure

Churchill Hospital

Patients are needed to participate in a clinical research study of Bortezomib, Thalidomide, Bendamustine and Dexamethasone to evaluate Multiple Myeloma, Chronic Kidney Disease, or Myeloma Renal Failure

Rheumatoid Arthritis

Nuffield Orthopaedic Centre

A clinical research study for the treatment of Rheumatoid Arthritis

Sarcoma

Churchill Hospital Updated

A clinical trial to evaluate treatments using Axitinib for patients with Soft Tissue Sarcoma

Skin Cancer

Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Soft Tissue Sarcoma

Churchill Hospital Updated

A clinical trial to evaluate treatments using Axitinib for patients with Soft Tissue Sarcoma

Solid Tumors

Churchill Hospital Updated

A clinical research study for the treatment of Neoplasm

Stroke

John Radcliffe Hospital

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Thromboembolism

John Radcliffe Hospital

A clinical trial to evaluate treatments for patients with Patients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke (WATCHMAN)

Ulcerative Colitis

Site Reference ID/Investigator# 129324

Patients are needed to participate in a clinical research study evaluating Adalimumab and Placebo for the treatment of Ulcerative Colitis

Ulcers

Site Reference ID/Investigator# 129324

Patients are needed to participate in a clinical research study evaluating Adalimumab and Placebo for the treatment of Ulcerative Colitis

Von Willebrand Disease

Churchill Hospital

Patients are needed to participate in a clinical research study evaluating Recombinant von Willebrand Factor (rVWF) for the treatment of Von Willebrand Disease